Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

IgA nephropathy, susceptibility to

MONDO:0100555

An inherited susceptibility or predisposition to developing IgA glomerulonephritis.

16 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Sub-types

IgA nephropathy, susceptibility to, 1 (16) IgA nephropathy, susceptibility to, 2 (0) IgA nephropathy, susceptibility to, 3 (0)

Broader categories

Inherited disease susceptibility (81) Disease susceptibility (3)

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 1 Completed 2 Terminated 2

New drug aims to slow kidney disease in IgA nephropathy patients

Disease control Ongoing

This phase 3 trial tests ravulizumab, a drug that blocks part of the immune system, against a placebo in 579 adults with IgA nephropathy—a kidney disease that can lead to kidney failure. The goal is to see if ravulizumab reduces protein in the urine and preserves kidney function …

Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC